Abstract:Vascular, Ahead of Print. IntroductionThoracic aortic aneurysms (TAAs) are an increasingly prevalent pathology with significant associated morbidity and mortality. Thoracic endovascular aortic repair (TEVAR) is the primary line of treatment. The purpose of this study was to analyse a single center's experience in the treatment of TAAs and identify possible risk factors for worse outcomes.MethodsA retrospective review of our institutional database was done to identify all patients treated for TAAs in a 10-year period, from 1 January 2012 to 31 December 2022. Data were extracted from patients' medical records. Primary outcome was all-cause mortality and secondary outcomes were procedure related morbidity (vascular access complications, medullary ischaemia, stroke, endoleaks, migration, aneurysm sac enlargement >5 mm) and need for reintervention at 1-, 6- and 12-month follow-up. A descriptive and inferential analysis of the data was performed. Statistical analyses were conducted using the IBM Statistical Package for Social Sciences (SPSS) software.ResultsWe identified 34 patients treated for TAAs in this period. Mean age was 68 years [47–87] and 79.4% of patients were male. Mean aneurysm diameter was 63 mm [35–100], 55.9% fusiform and 44.1% saccular. The majority (91.2%) were located at the descending thoracic aorta and 3 (8.8%) of them extended to the aortic arch. The most common aetiology was degenerative in 22 patients (64.7%), followed by aortic dissection in 8 patients (23.5%). Elective surgery was performed in 19 (61.3%) patients and 12 (38.7%) had urgent repair. TEVAR was the treatment of choice in 24 (77.4%) patients, and the remaining 7 (22.6%) were treated with hybrid surgery. Mean length of hospital stay was 10 days [2–80] (6 days for elective repair versus 16 days for urgent repair, p = .016). Follow-up period ranged from 1 month to 10 years. At 1 year follow-up, all-cause mortality was 15%, morbidity was 30% (with 6 (22%) patients having a type Ia endoleak) and need for reintervention was 22%. Aneurysm diameter was a significant risk factor for procedure related morbidity (median diameter of 73.5 mm versus 56.0 mm in patients with no morbidity; p = .027). The presence of type Ia endoleak was significantly associated with higher reintervention rates (p = .001), but not with higher mortality rates (p = .515). Age, female sex, aetiology and urgent repair weren't associated with any significant differences in the outcomes.ConclusionsTEVAR proved to be effective in the treatment of TAAs, with good outcomes at short and mid-term follow-up. TAAs should be diagnosed earlier and be promptly treated when meeting criteria to prevent worse outcomes.

Predictors for reintervention and survival during long-term follow-up after TEVAR for descending thoracic aortic aneurysm

Long-Term Aortic Remodeling after Thoracic Endovascular Aortic Repair of Acute, Subacute, and Chronic Type B Dissections.

Long-term outcomes of TEVAR for thoracic aortic diseases: a retrospective single-center study

Results of the VALOR II trial of the Medtronic Valiant Thoracic Stent Graft

Improved midterm outcomes after endovascular repair of nontraumatic descending thoracic aortic rupture compared with open surgery

Mid-term Outcomes from a Multicenter Study: is TEVAR Safe for Ascending Aortic Dissection?

Long-term results of etiology-based thoracic endovascular aortic repair: a single-center experience

Long-term Outcomes of Thoracic Endovascular Aortic Repair for Chronic Stanford Type B Aortic Dissection

Reintervention after Thoracic Endovascular Aortic Repair of Uncomplicated Type B Aortic Dissection

Outcomes of endovascular treatment of thoracic aorta pathologies: 10-year single-center results

Long-term Outcomes of Endovascular Repair for Blunt Thoracic Aortic Injury: A 10 Year Multi-center Experience

Outcomes and Aortic Remodelling after Proximal Thoracic Endovascular Aortic Repair of Post Type B Aortic Dissection Thoracic Aneurysm

Long-term survival and ourtomes a large cohort of patients underwent with Transcatheter Aortic Valve Replacement: an 10-year single center TAVR experience

Perioperative and Mid-Term Outcomes

Thoracic aortic aneurysms, a single center's 10-years experience and analysis of outcomes

Clinical Outcomes and Factors Associated With Aortic Shrinkage After Thoracic Endovascular Aortic Repair for Aneurysmal Chronic Aortic Dissection

Long-term Results of Thoracic Endovascular Aortic Repair for Type B Aortic Dissection and Risk Factors for Survival

16-year outcomes of blunt thoracic aortic injury treated with thoracic endovascular aortic repair: A single-institution experience

Mid-Term Outcomes Following TEVAR for Chronic Type B Aortic Dissection

Long-Term Outcomes in Patients Managed with the EndurantTM Endograft under Elective Setting

High mortality rates after both open surgical and endovascular thoracic aortic interventions in patients with end-stage renal disease